Aurora Cannabis Inc (TSE:ACB) – Equities researchers at Seaport Global Securities lowered their Q3 2020 earnings per share estimates for Aurora Cannabis in a research report issued on Tuesday, May 28th, according to Zacks Investment Research. Seaport Global Securities analyst B. Hundley now anticipates that the company will earn ($0.01) per share for the quarter, down from their previous forecast of $0.01. Seaport Global Securities also issued estimates for Aurora Cannabis’ Q4 2020 earnings at $0.01 EPS.
Aurora Cannabis (TSE:ACB) last announced its earnings results on Tuesday, May 14th. The company reported C($0.10) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of C($0.05) by C($0.05). The company had revenue of C$65.15 million during the quarter, compared to analyst estimates of C$68.05 million.A number of other research firms have also recently commented on ACB. Jefferies Financial Group reissued a “buy” rating and set a C$12.00 price target on shares of Aurora Cannabis in a report on Monday, February 25th. Cowen restated an “outperform” rating and set a C$14.00 target price on shares of Aurora Cannabis in a research report on Tuesday, March 5th. Bank of America reiterated a “buy” rating and issued a C$15.00 price target on shares of Aurora Cannabis in a report on Wednesday, April 17th. Finally, Desjardins reissued a “buy” rating and issued a C$16.50 price objective on shares of Aurora Cannabis in a research note on Friday, April 26th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of C$14.58.
ACB traded down C$0.18 during trading on Wednesday, hitting C$9.65. The stock had a trading volume of 8,448,000 shares, compared to its average volume of 12,773,262. The company has a market capitalization of $9.77 billion and a PE ratio of -38.29. The company has a debt-to-equity ratio of 14.55, a current ratio of 2.37 and a quick ratio of 1.80. Aurora Cannabis has a one year low of C$5.29 and a one year high of C$16.24.
In related news, Senior Officer Allan John Cleiren sold 33,000 shares of Aurora Cannabis stock in a transaction on Monday, April 22nd. The stock was sold at an average price of C$12.12, for a total transaction of C$399,960.00. Following the completion of the sale, the insider now owns 51,120 shares of the company’s stock, valued at C$619,574.40.
About Aurora Cannabis
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Featured Article: How to Invest in Growth Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.